<?xml version="1.0" encoding="UTF-8"?>
<!DOCTYPE root>
<article xmlns:mml="http://www.w3.org/1998/Math/MathML" xmlns:xlink="http://www.w3.org/1999/xlink" xmlns:xsi="http://www.w3.org/2001/XMLSchema-instance" xmlns:ali="http://www.niso.org/schemas/ali/1.0/" article-type="other" dtd-version="1.2" xml:lang="en"><front><journal-meta><journal-id journal-id-type="publisher-id">Neuromuscular Diseases</journal-id><journal-title-group><journal-title xml:lang="en">Neuromuscular Diseases</journal-title><trans-title-group xml:lang="ru"><trans-title>Нервно-мышечные болезни</trans-title></trans-title-group></journal-title-group><issn publication-format="print">2222-8721</issn><issn publication-format="electronic">2413-0443</issn><publisher><publisher-name xml:lang="en">Publishing House ABV Press</publisher-name></publisher></journal-meta><article-meta><article-id pub-id-type="publisher-id">261</article-id><article-id pub-id-type="doi">10.17650/2222-8721-2018-8-1-34-37</article-id><article-categories><subj-group subj-group-type="toc-heading" xml:lang="en"><subject>ORIGINAL REPORTS</subject></subj-group><subj-group subj-group-type="toc-heading" xml:lang="ru"><subject>ОРИГИНАЛЬНЫЕ ИССЛЕДОВАНИЯ</subject></subj-group><subj-group subj-group-type="article-type"><subject></subject></subj-group></article-categories><title-group><article-title xml:lang="en">Lamb–Shaffer syndrome, deferred outside not described by SOX5 mutation</article-title><trans-title-group xml:lang="ru"><trans-title>Синдром Ламб–Шаффера, обусловленный ранее не описанной мутацией в гене SOX5</trans-title></trans-title-group></title-group><contrib-group><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0002-5819-4835</contrib-id><name-alternatives><name xml:lang="en"><surname>Sharkova</surname><given-names>I. V.</given-names></name><name xml:lang="ru"><surname>Шаркова</surname><given-names>И. В.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><email>sharkova-inna@rambler.ru</email><xref ref-type="aff" rid="aff1"/></contrib><contrib contrib-type="author"><contrib-id contrib-id-type="orcid">https://orcid.org/0000-0001-5602-2805</contrib-id><name-alternatives><name xml:lang="en"><surname>Dadali</surname><given-names>E. L.</given-names></name><name xml:lang="ru"><surname>Дадали</surname><given-names>Е. Л.</given-names></name></name-alternatives><address><country country="RU">Russian Federation</country></address><xref ref-type="aff" rid="aff1"/></contrib></contrib-group><aff-alternatives id="aff1"><aff><institution xml:lang="en">Research Center of Medical Genetics</institution></aff><aff><institution xml:lang="ru">ФБГНУ «Медико-генетический научный центр»</institution></aff></aff-alternatives><pub-date date-type="pub" iso-8601-date="2018-04-30" publication-format="electronic"><day>30</day><month>04</month><year>2018</year></pub-date><volume>8</volume><issue>1</issue><issue-title xml:lang="en"/><issue-title xml:lang="ru"/><fpage>34</fpage><lpage>37</lpage><history><date date-type="received" iso-8601-date="2018-04-30"><day>30</day><month>04</month><year>2018</year></date><date date-type="accepted" iso-8601-date="2018-04-30"><day>30</day><month>04</month><year>2018</year></date></history><permissions><copyright-statement xml:lang="en">Copyright ©; 2018, Sharkova I.V., Dadali E.L.</copyright-statement><copyright-statement xml:lang="ru">Copyright ©; 2018, Шаркова И.В., Дадали Е.Л.</copyright-statement><copyright-year>2018</copyright-year><copyright-holder xml:lang="en">Sharkova I.V., Dadali E.L.</copyright-holder><copyright-holder xml:lang="ru">Шаркова И.В., Дадали Е.Л.</copyright-holder><ali:free_to_read xmlns:ali="http://www.niso.org/schemas/ali/1.0/"/><license><ali:license_ref xmlns:ali="http://www.niso.org/schemas/ali/1.0/">https://creativecommons.org/licenses/by/4.0</ali:license_ref></license></permissions><self-uri xlink:href="https://nmb.abvpress.ru/jour/article/view/261">https://nmb.abvpress.ru/jour/article/view/261</self-uri><abstract xml:lang="en"><p>Clinical and genetic characteristics of a patient with Lamb–Shaffer syndrome due to the newly discovered heterozygous missense mutation p.1868A&gt;C in the 14 exon of the SOX5 gene are presented in the next generation sequencing of exom. It is shown that, in contrast to the previously described patients due to the presence of a deletion in the region of the gene or segment of chromosome 12p12.1, in the presence of missense mutation, the intellectual deficit and the dysmorphic features of the structure are not pronounced sharply and there is no anomaly in the development of other organs and systems.</p></abstract><trans-abstract xml:lang="ru"><p><italic>Представлены клинико-генетические характеристики больного с синдромом Ламб–Шаффера, обусловленным впервые выявленной гетерозиготной миссенс-мутацией с.1868А&gt;С в экзоне 14 гена SOX5 при проведении секвенирования экзома нового поколения. Показано, что в отличие от ранее описанных больных c синдромом Ламб–Шаффера, обусловленным наличием делеции в области гена или участка хромосомы 12р12.1, при миссенс-мутации интеллектуальный дефицит и дисморфические черты строения выражены нерезко и отсутствуют аномалии развития других органов и систем.</italic></p><p> </p></trans-abstract><kwd-group xml:lang="en"><kwd>Lamb–Shaffer syndrome</kwd><kwd>exome sequencing</kwd><kwd>SOX5 gene</kwd><kwd>monogenic syndromes</kwd><kwd>retardation of motor and speech development</kwd><kwd>intellectual deficiency</kwd></kwd-group><kwd-group xml:lang="ru"><kwd>синдром Ламб–Шаффера</kwd><kwd>секвенирование экзома нового поколения</kwd><kwd>ген SOX5</kwd><kwd>моногенные синдромы</kwd><kwd>задержка моторного и речевого развития</kwd><kwd>интеллектуальный дефицит</kwd></kwd-group><funding-group/></article-meta></front><body></body><back><ref-list><ref id="B1"><label>1.</label><citation-alternatives><mixed-citation xml:lang="en">1. Ikeda T., Zhang J., Chano T. et al. Identification and characterization of the human long form of SOX5 (L-SOX5) gene. Gene 2002;298(1):59–68. DOI: 10.1016/S0378- 1119(02)00927-7. PMID: 12406576.</mixed-citation><mixed-citation xml:lang="ru">Ikeda T., Zhang J., Chano T. et al. Identification and characterization of the human long form of SOX5 (L-SOX5) gene. Gene 2002;298(1):59–68. DOI: 10.1016/S0378- 1119(02)00927-7. PMID: 12406576.</mixed-citation></citation-alternatives></ref><ref id="B2"><label>2.</label><citation-alternatives><mixed-citation xml:lang="en">2. Kwan K.Y., Lam M.M., Krsnik Ž. et al. SOX5 postmitotically regulates migration, postmigratory differentiation, and projections of subplate and deep-layer neocortical neurons. Proc Natl Acad Sci USA 2008;105(41):16021–6. DOI: 10.1073/ pnas.0806791105. PMID: 18840685.</mixed-citation><mixed-citation xml:lang="ru">Kwan K.Y., Lam M.M., Krsnik Ž. et al. SOX5 postmitotically regulates migration, postmigratory differentiation, and projections of subplate and deep-layer neocortical neurons. Proc Natl Acad Sci USA 2008;105(41):16021–6. DOI: 10.1073/ pnas.0806791105. PMID: 18840685.</mixed-citation></citation-alternatives></ref><ref id="B3"><label>3.</label><citation-alternatives><mixed-citation xml:lang="en">3. Kamachi Y., Kondoh H. SОХ proteins: regulators of cell fate specification and differentiation. Development 2013;140(20):4129–44. DOI: 10.1242/ dev.091793. PMID: 24086078.</mixed-citation><mixed-citation xml:lang="ru">Kamachi Y., Kondoh H. SОХ proteins: regulators of cell fate specification and differentiation. Development 2013;140(20):4129–44. DOI: 10.1242/ dev.091793. PMID: 24086078.</mixed-citation></citation-alternatives></ref><ref id="B4"><label>4.</label><citation-alternatives><mixed-citation xml:lang="en">4. Lee R.W., Bodurtha J., Cohen J. et al. Deletion 12p12 involving SOX5 in two children with developmental delay and dysmorphic features. Pediatr Neurol 2013;48(4):317–20. DOI: 10.1016/j.pediatrneurol.2012.12.013. PMID: 23498568.</mixed-citation><mixed-citation xml:lang="ru">Lee R.W., Bodurtha J., Cohen J. et al. Deletion 12p12 involving SOX5 in two children with developmental delay and dysmorphic features. Pediatr Neurol 2013;48(4):317–20. DOI: 10.1016/j.pediatrneurol.2012.12.013. PMID: 23498568.</mixed-citation></citation-alternatives></ref><ref id="B5"><label>5.</label><citation-alternatives><mixed-citation xml:lang="en">5. Lamb A.N., Rosenfeld J.A., Neill N.J. et al. Haploinsufficiency of SOX5 at 12p12.1 is associated with developmental delays with prominent language delay, behavior problems, and mild dysmorphic features. Hum Mutat 2012;33(4):728–40. DOI: 10.1002/humu.22037. PMID: 22290657.</mixed-citation><mixed-citation xml:lang="ru">Lamb A.N., Rosenfeld J.A., Neill N.J. et al. Haploinsufficiency of SOX5 at 12p12.1 is associated with developmental delays with prominent language delay, behavior problems, and mild dysmorphic features. Hum Mutat 2012;33(4):728–40. DOI: 10.1002/humu.22037. PMID: 22290657.</mixed-citation></citation-alternatives></ref><ref id="B6"><label>6.</label><citation-alternatives><mixed-citation xml:lang="en">6. Nesbitt A., Bhoj E.J., McDonald Gibson K. et al. Exome sequencing expands the mechanism of SOX5-associated intellectual disability: a case presentation with review of SOX-related disorders. Am J Med Genet 2015;167A(11):2548–54. DOI: 10.1002/ ajmg.a.37221. PMID: 26111154.</mixed-citation><mixed-citation xml:lang="ru">Nesbitt A., Bhoj E.J., McDonald Gibson K. et al. Exome sequencing expands the mechanism of SOX5-associated intellectual disability: a case presentation with review of SOX-related disorders. Am J Med Genet 2015;167A(11):2548–54. DOI: 10.1002/ ajmg.a.37221. PMID: 26111154.</mixed-citation></citation-alternatives></ref><ref id="B7"><label>7.</label><citation-alternatives><mixed-citation xml:lang="en">7. Schanze I., Schanze D., Bacino C.A. et al. Haploinsufficiency of SOX5, a member of the SOX (SRY-related HMG-box) family of transcription factors is a cause of intellectual disability. Eur J Med Genet 2013;56(2):108–13. DOI: 10.1016/j. ejmg.2012.11.001. PMID: 23220431.</mixed-citation><mixed-citation xml:lang="ru">Schanze I., Schanze D., Bacino C.A. et al. Haploinsufficiency of SOX5, a member of the SOX (SRY-related HMG-box) family of transcription factors is a cause of intellectual disability. Eur J Med Genet 2013;56(2):108–13. DOI: 10.1016/j. ejmg.2012.11.001. PMID: 23220431.</mixed-citation></citation-alternatives></ref><ref id="B8"><label>8.</label><citation-alternatives><mixed-citation xml:lang="en">8. Lelieveld S.H., Reijnders M.R., Pfundt R. et al. Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability. Nat Neurosci 2016;19(9): 1194–6. DOI: 10.1038/nn.4352. PMID: 27479843.</mixed-citation><mixed-citation xml:lang="ru">Lelieveld S.H., Reijnders M.R., Pfundt R. et al. Meta-analysis of 2,104 trios provides support for 10 new genes for intellectual disability. Nat Neurosci 2016;19(9): 1194–6. DOI: 10.1038/nn.4352. PMID: 27479843.</mixed-citation></citation-alternatives></ref><ref id="B9"><label>9.</label><citation-alternatives><mixed-citation xml:lang="en">9. Zech M., Poustka K., Boesch S. et al. SOX5-null heterozygous mutation in a family with adult-onset hyperkinesia and behavioral abnormalities. Case Rep Genet 2017;2017:2721615. DOI: 10.1155/2017/ 2721615. PMID: 29214085.</mixed-citation><mixed-citation xml:lang="ru">Zech M., Poustka K., Boesch S. et al. SOX5-null heterozygous mutation in a family with adult-onset hyperkinesia and behavioral abnormalities. Case Rep Genet 2017;2017:2721615. DOI: 10.1155/2017/ 2721615. PMID: 29214085.</mixed-citation></citation-alternatives></ref></ref-list></back></article>
